Search - tctmd.com

Displaying 281 - 300 of 616

Sort: Relevancy | Date

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Conference News SCAI 2020

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

Caitlin E. Cox

May 25, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

News Daily News

Contentious Medical Device Tax May Soon Be Gone for Good

Yael L. Maxwell

December 20, 2019

Presentation Live Valves 2019

How Should We Assess Bioprosthetic Valve Durability?

Presenter: Danny Dvir

December 10, 2019

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

Podcast TCTMD Talking Points

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

October 25, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Presenter: Adam Greenbaum

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Presenter: Adnan Chhatriwalla

September 27, 2019

Advertisement

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

July 2020 News Roundup

Device Explants After TAVR Rare but Risky

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Contentious Medical Device Tax May Soon Be Gone for Good

How Should We Assess Bioprosthetic Valve Durability?

Routine Anticoagulation Seems Warranted After TMVR: Review

Signal of Impaired Sapien XT Durability in Midterm Follow-up

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content